FiercePharma: FDA weighs Teva's request to bring Plan B contraceptive out from behind the pharmacists' counter. News | Follow @FiercePharma
> Roche's Genentech unit and Biogen Idec ($BIIB) are appealing a judgment in favor of GlaxoSmithKline ($GSK) in a patent fight over the blood cancer drug Arzerra. Report
> Ranbaxy Laboratories has launched its generic version of Pfizer's ($PFE) blood-pressure drug Caduet in the U.S. News
> GlaxoSmithKline ($GSK) has nabbed one necessary approval for its offshore wind-turbine site near Montrose in Scotland. Item
> Ex-NFL players are suing the league and its teams, saying they were given the blood-thinning painkiller Toradol before and during games, worsening injuries such as concussions. Story
> India's Elder Pharmaceuticals is poised to jump into the Japanese market, armed with regulatory approval for its API plant in Patalganga. Piece
> Cobb County, GA gave Osmotica Pharmaceutical a $564,539 tax break in exchange for creating 144 jobs at a former Solvay Pharmaceuticals site. More
> Asahi Kasei Pharma launched its subcutaneous injectable form of Teribone, an osteoporosis remedy, in Japan. Report
Biotech News
@FierceBiotech: Biogen Idec signs up with Samsung on $300 million biosimilars venture. News | Follow @FierceBiotech
@JohnCFierce: Sustained release levodopa/carbidopa (xenoport) fails Ph2 Parkinson's study. Does anyone really understand this field? Report | Follow @JohnCFierce
@RyanMFierce: Sanofi's GLP-1 drug yields upbeat data in pivotal study in T2DM. GLP-1 class growing beyond Byetta/Bydureon, Victoza. Item | Follow @RyanMFierce
@FierceMedDev: Randox's new molecular diagnostic test permits quick selection of colorectal cancer patients for Anti-EGFR therapy. Release | Follow @FierceMedDev
> Merck blueprints Asian R&D HQ in Beijing in $1.5B research blitz. News
Biotech Research News
> Partial, lab-grown pituitary gland works in mice. News
> Gene may hold back skin, head, neck cancers. Story
> Researchers unmask protein as villain in pancreatic, brain cancer growth. Item
> Search is on for new anti-addiction drug targets. Article
> Adult stem cell pathway could yield better muscle disorder treatments. Report
Manufacturing News
> Pfizer presence unmistakable in 1940s Brooklyn. News
> MA anticipates bioprocess job increase. Item
> Theravance MRSA drug a victim of Ben Venue shutdown. Report
> Issue separates bio, small molecule CMOs. News
> Online vaccines available from suspect sources. Article
And Finally... Flu vaccination rates are up this year, especially among children. Report